NCT00002058View on ClinicalTrials.gov

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Mycobacterium Avium-intracellulare InfectionHIV Infections

Interventions

DRUG

Clofazimine

Trial Locations (2)

90048

Keith Med Group, Los Angeles

941102859

San Francisco Gen Hosp, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER

NCT00002058 - A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease | Biotech Hunter | Biotech Hunter